Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | DTIL Precision BioSciences, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $6.67 -0.0% | $15.06 -2.0% |
| StockIQ Score | 42D Weak Risk: High | 36F Weak Risk: Medium |
| Technical | 23F | 13F |
| Fundamental | 30F | 35F |
| Growth | 32F | 50C- |
| Fair Value | 55C | 38F |
| News | 92A+ | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
DTIL outperforms in valuation (50 vs. 38) and fundamental analysis (30 vs. 35), making it stronger in stability and price relative to earnings. However, AAPG leads in growth potential (50 vs. 32), suggesting faster expansion. Both share a "WEAK" rating, but DTIL’s technical score (23 vs. 18) hints at slightly better short-term trading conditions.
